Clinical Trials Logo

Solitary Pulmonary Nodule clinical trials

View clinical trials related to Solitary Pulmonary Nodule.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT04574518 Enrolling by invitation - Tobacco Use Clinical Trials

Teachable Moment to Opt-out of Tobacco: Interactive Voice Response Quit Line for Veteran Active Smokers With Lung Nodules

TeaMOUT
Start date: August 12, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of a smoking cessation outreach intervention (TeaM OUT) on increasing use of smoking cessation resources in Veterans. The hypotheses are 1) patients included in the TeaM OUT group will have higher accession of cessation services, such as counseling and medication therapies, compared to patients in enhanced usual care and 2) more patients in the TeaM OUT group will have quit smoking at one year after the intervention. Veterans with a recently diagnosed lung nodule who currently smoke will receive the TeaM OUT intervention or Enhanced Usual Care. The TeaM OUT intervention has 2 parts: 1) a letter that a) describes the nodule and the importance of cessation related to the pulmonary nodule (i.e. teachable moment) and b) notification that a Proactive IVR Quit Line will initiate contact and 2) call(s) from the Proactive IVR Quit Line which a) offers smoking cessation resources and b) helps connect the patient to those resources. The enhanced usual care group will receive a letter that provides information about how to contact the IVR Quit Line. The IVR system will track referrals to cessation services. Additional information about smoking status and use of cessation resources will be collected from the electronic health record and surveys. .

NCT ID: NCT02531646 Enrolling by invitation - Clinical trials for Solitary Pulmonary Nodules

Clinical Evaluation of CARESTREAM Dual Energy and Digital Tomosynthesis

Start date: November 2015
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate the imaging performance of Dual Energy and Digital Tomosynthesis (DE-DT) application against the commercially available predicate devices.

NCT ID: NCT01465425 Enrolling by invitation - Clinical trials for Pancreatic Neoplasms

Extracolonic Findings on Computed Tomography (CT) Colonography

ACRIN7151
Start date: September 2011
Phase:
Study type: Observational

The ACRIN 7151 trial will use medical records abstraction data from participants with extracolonic findings (ECFs) reported from the ACRIN 6664 National CT Colonography Trial to: 1) measure incidence of diagnostic imaging, hospitalization, and interventional procedures associated with ECFs reported on computed tomography colonography (CTC), delineated by type of ECF; 2) determine potential predictors of follow-up diagnostic imaging, hospitalization, and interventional procedures, delineated by type of ECF; and 3) evaluate the clinical/pathologic diagnoses associated with indeterminate but potentially significant ECFs. These data can be used to incorporate ECFs into existing models on the cost-effectiveness of CTC in colorectal cancer screening and can potentially be used to develop guidelines for the reporting and management of ECFs.